{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:45:53Z","timestamp":1771472753938,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jviromet.2021.114122","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T18:38:37Z","timestamp":1615228717000},"page":"114122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2"],"prefix":"10.1016","volume":"292","author":[{"given":"Katharina","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Girl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"von Buttlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Dobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"W\u00f6lfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2021.114122_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138861","article-title":"COVID-19: disease, management, treatment, and social impact","volume":"728","author":"Ali","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jviromet.2021.114122_bib0010","article-title":"SARS-CoV-2 neutralizing antibody titers in convalescent plasma and recipients in New Mexico: an open treatment study in COVID-19 patients","author":"Bradfute","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2021.114122_bib0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","article-title":"Rational vaccine design in the time of COVID-19","volume":"27","author":"Burton","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jviromet.2021.114122_bib0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate Covid-19","author":"Gandhi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2021.114122_bib0025","article-title":"Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment","author":"GeurtsvanKessel","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jviromet.2021.114122_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024135","article-title":"Rapid titration of measles and other viruses: optimization with determination of replication cycle length","volume":"6","author":"Grigorov","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2021.114122_bib0035","article-title":"Convalescent plasma therapy for the treatment of patients with COVID-19: assessment of methods available for antibody detection and their correlation with neutralising antibody levels (preprint)","author":"Harvala","year":"2020","journal-title":"Infect. Dis. (except HIV\/AIDS)"},{"key":"10.1016\/j.jviromet.2021.114122_bib0040","article-title":"Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing","volume":"1","author":"Haselmann","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.jviromet.2021.114122_bib0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00108-020-00853-6","article-title":"Die Virologie von SARS-CoV-2","volume":"61","author":"Hoehl","year":"2020","journal-title":"Der Internist"},{"key":"10.1016\/j.jviromet.2021.114122_bib0050","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.18.2000603","article-title":"Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples","volume":"25","author":"J\u00e4\u00e4skel\u00e4inen","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jviromet.2021.114122_bib0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jviromet.2021.114122_bib0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114122_bib0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2021.114122_bib0070","first-page":"1","article-title":"Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)","author":"Meyer","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2021.114122_bib0075","article-title":"A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation (preprint)","author":"Muruato","year":"2020","journal-title":"Microbiology"},{"key":"10.1016\/j.jviromet.2021.114122_bib0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"July (7)","key":"10.1016\/j.jviromet.2021.114122_bib0085","article-title":"Severe acute respiratory syndrome coronavirus 2\u2212specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis. J. CDC"},{"key":"10.1016\/j.jviromet.2021.114122_bib0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","article-title":"Developing antibody tests for SARS-CoV-2","volume":"395","author":"Petherick","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114122_bib0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: the major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.jviromet.2021.114122_bib0100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2021.114122_bib0105","series-title":"Johns Hopkins Center for Health Security","author":"Website Global Progress on COVID-19 Serology-Based Testing","year":"2020"},{"key":"10.1016\/j.jviromet.2021.114122_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bsheal.2020.08.004","article-title":"Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro","author":"Yang","year":"2020","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.jviromet.2021.114122_bib0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:53:56Z","timestamp":1759056836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093421000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"alternative-id":["S0166093421000616"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114122","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114122"}}